The recently published 'Cass Review' in the UK has led the country's National Health Services to issue the decision that puberty-suppressing hormones will no longer be prescribed to minors. This decision has been met with mixed reactions and questions asking how the UK's stance on transgender care will affect the rest of the world.
By Paulette Freixas
It’s a fact of university life: alongside lecture notes and case briefs, many laptops quietly house a library of free textbook PDFs....
